Cas 1388893-18-2,N,N-dimethyl-4-(thieno[2,3-b]pyridin-4-yl)cyclohexan-1-amine

1388893-18-2

Post Buying Request

Basic information

Product Name: N,N-dimethyl-4-(thieno[2,3-b]pyridin-4-yl)cyclohexan-1-amine
Synonyms: N,N-dimethyl-4-(thieno[2,3-b]pyridin-4-yl)cyclohexan-1-amine
CAS NO:1388893-18-2
Molecular Formula:
Molecular Weight: 276.403
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N,N-dimethyl-4-(thieno[2,3-b]pyridin-4-yl)cyclohexan-1-amine(CAS DataBase Reference)
NIST Chemistry Reference: N,N-dimethyl-4-(thieno[2,3-b]pyridin-4-yl)cyclohexan-1-amine(1388893-18-2)
EPA Substance Registry System: N,N-dimethyl-4-(thieno[2,3-b]pyridin-4-yl)cyclohexan-1-amine(1388893-18-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1388893-18-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1388893-18-2 Suppliers

Recommended suppliers

1388893-18-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1388893-18-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,8,8,8,9 and 3 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1388893-18:
(9*1)+(8*3)+(7*8)+(6*8)+(5*8)+(4*9)+(3*3)+(2*1)+(1*8)=232
232 % 10 = 2
So 1388893-18-2 is a valid CAS Registry Number.

1388893-18-2Upstream product

62226-17-9 4-chlorothieno<2,3-b>pyridine

1388893-18-2Downstream Products

1388893-18-2Relevant academic research and scientific papers

IRAK INHIBITORS AND USES THEREOF

-

Page/Page column 221, (2012/07/28)

The present invention relates to compounds and methods useful for inhibiting one or more interleukin-l receptor-associated kinases ("IRAK"). In some embodiments, a provided compound inhibits IRAK-1 and IRAK-4. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of various disorders.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1388893-18-2